McCormick reported a 16.7% increase in net sales for Q2, driven mainly by acquisitions and favorable currency effects, while organic growth stayed weak. The company's gross margin improved by 270 basis points to 40.2%, supported by acquisitions, pricing strategies, product mix, and cost savings from its CCI program. Despite these operational gains and a solid dividend, McCormick's long-term growth outlook appears limited, with shares underperforming and no clear signs of a turnaround. Investors remain cautious, watching the potential Unilever merger for future catalysts.
McCormick & Company reported fiscal Q2 2026 earnings of $0.80 per share, beating analyst estimates of $0.70, with revenue of $1.94 billion surpassing expectations. Net sales grew 16.7% year-over-year, boosted by currency effects and the McCormick de ...
McCormick & Company posted a 16.7% increase in net sales for Q2 2026, driven by acquisitions and organic growth, with adjusted operating income up 30%. The company reaffirmed its 2026 outlook, expecting continued sales and earnings growth supported b...
McCormick & Company announced a quarterly dividend of $0.48 per share, payable on July 20, 2026, to shareholders of record as of July 6, 2026. This dividend continues the company's impressive streak of 102 consecutive years of dividend payments. McCo...
McCormick & Company will release its Q2 earnings report before the market opens on June 25. Analysts forecast earnings of 70 cents per share, up from 69 cents last year, and revenue of $1.91 billion, compared to $1.66 billion previously. The company ...
